Apr 11
|
Fagron publishes agenda for 2025 annual shareholders meeting
|
Apr 10
|
Fagron to present its upgraded growth strategy and mid-term financial targets at its Capital Markets Day 2025
|
Apr 10
|
Record first-quarter revenue of €239 million, reflecting 14% topline growth
|
Feb 20
|
Fagron delivers exceptional performance with 14% topline growth and 17% increase in REBITDA for FY 2024
|
Jan 7
|
Fagron strengthens its market positioning with the acquisitions of CareFirst in North America and Injeplast in Brazil
|